Summary The efficacy of three murine monoclonal antibodies (MAbs) for immunoscintigraphy of small-cell lung cancer (SCLC) xenografts was studied in a Balb/c nu/nu mouse model. These MAbs, 123C3, 123A8 and MOCl91, belong to cluster 1 of anti-SCLC MAbs and bind to the neural cell adhesion molecule (NCAM) with similar affinity. After intraperitoneal injection of these MAbs, labelled with 1251, the highest uptake in tumour tissue was obtained with MAb 123C3. Seven days after administration of this MAb 13.9% of the injected dose per gram of tumour tissue was retained in the tumour. The corresponding tumour to tissue ratios ranged from 3.97 for blood to 31.03 for colon. The imaging results and the tumour uptake were less favourable for the two other MAbs, 123A8 and MOCl91 (fractions of injected dose respectively 6.7% and 9.2%), although affinity, biological activity after labelling and uptake in non-tumour tissues were very similar for all three MAbs. These results may be explained by the differences in the interaction between the MAbs and the tumour cells. MAb 123C3 is internalised into tumour cells, whereas both other anti-NCAM MAbs are not. Internalisation into NCI H69 cells was demonstrated in vitro by a radioimmunoassay, confocal laser scanning microscopy and electron microscopy. The internalised fraction of MAb 123C3 was 22.3% after 24 h, whereas this fraction was only 7.5% for MAb 123A8. Although the internalised radiolabelled MAbs are usually degraded and dehalogenated intracellularly, the retained radioactivity is high. Apparently, intracellular degradation of radiolabelled MAb 123C3 and subsequent secretion of radioactive iodine did not prevent the accumulation of intracellular radioactivity. In conclusion, accumulation and retention of radioactivity in the tumour tissue, due to internalisation of radiolabelled MAbs, may improve the results of immunoscintigraphy.
Clinically, lung cancer is divided into small-cell lung cancer (SCLC) and non-small-cell lung cancer (NSCLC). SCLC accounts for about 25% of the cases and is associated with the worst prognosis of all lung cancers (Yesner, 1985) . For the prognosis and treatment of this type of tumour it is very important to determine the initial stage of the tumour (Ihde, 1985) . Unfortunately, standard staging procedure is very laborious and inaccurate. In a recent meta-analysis, the best non-invasive diagnostic technique, computerised tomography (CT), achieved an accuracy of only 0.80 for the detection of intrathoracic lesions (Dales et al., 1990) . There is clearly a need for new techniques with a higher sensitivity and specificity to replace the multitude of diagnostic procedures used in the initial staging (Ihde, 1985) . Monoclonal antibodies (MAbs) have greatly increased the sensitivity in detecting bone marrow metastases in SCLC (Ledermann et al., 1994) . Using radiolabelled MAbs in patients with SCLC (Nelp et al., 1990 ) distant metastases can be detected by immunoscintigraphy in 10% of patients with limited disease, when staged by conventional methods. This finding suggests that immunoscintigraphy has a higher sensitivity than the standard staging procedure.
Monoclonal antibodies (MAbs) raised against SCLC are categorised in clusters by the antigen recognised, according to an international workshop (Beverley et al., 1988) . The MAbs belonging to cluster 1 bind to the neural cell adhesion molecule (NCAM) (Moolenaar et al., 1990) . Of the existing NCAM isoforms, are the most important in SCLC (Moolenaar et al., 1990 ) and all three cluster 1 MAbs used in this study recognise these isoforms (Beverley et al., 1988; Hida et al., 1991) . As NCAM is expressed by all SCLCs, it seems a suitable target for immunoscintigraphy with these MAbs. The three MAbs investigated in this study showed similar affinities for NCAM and were used for radioimmunodetection in a mouse SCLC xenograft model. We demonstrated that one of the MAbs that is internalised by the SCLC cells shows a significantly higher uptake in tumour tissue.
Materials and methods Cell lines
The NCI H69 cell line (hereafter referred to as H69 cells), derived from a small cell lung carcinoma, was kindly provided by Dr D Carney (Gazdar et al., 1980) and was grown in Dulbecco's modified Eagle medium supplemented with 1 mm glutamine, 10% fetal calf serum and antibiotics. This cell line expresses high levels of NCAM when grown in vitro and as xenografts in nude mice (Rygaard et al., 1992) .
Monoclonal antibodies From a panel of nine cluster 1 MAbs, MAbs 123C3, 123A8 and MOCl91 were selected for this study, on the basis of their affinity for NCAM and biological activity after labelling with radioactive iodine (Beverley et al., 1988; Moolenaar et al., 1990) . MAbs 123C3 and 123A8 are IgGI antibodies raised at our institute against a membrane fraction of a fresh SCLC specimen. Both MAbs recognise epitopes on the protein backbone of NCAM close to the attachment site of the polysialic acid side-chains (Gerardy-Shahn and Eckhardt, 1994) and bind to all NCAM isoforms (Moolenaar et al., 1990 ). The tissue distribution of MAb 123C3 in human tissues was described previously (Schol et al., 1988 , 1985) .
Antibody labelling
The MAbs were labelled with 1251 (Amersham) using the chloramine-T method (Hunter and Greenwood, 1962 Cell-surface bound and intracellular radioactivity were determined by measuring the cell-associated radioactivity before and after treatment with low-pH buffer (see above). showed a high background and a relatively low tumour uptake, whereas the images made on day 7 had a relatively low background and higher tumour uptake and were judged to be optimal ( Figure  1 ). These results were confirmed by quantifying the counts from the images. The mean tumour to background ratio obtained from the images made with MAb 123C3 showed an increase from 1.03 on day 2 to 1.99 on day 7, whereas for MAbs MOC191 and 123A8 the values remained constant at 1.13 and 1.05. Images made with radiolabelled MAb 123C3 showed a higher tumour uptake, resulting in a more distinct localisation of the tumour than the images produced with MAbs MOC191 and 123A8. The larger tumours showed a higher total radioactive count than the smaller ones. Images made with M6/1, the control antibody, showed no tumour at all, and a higher background activity than the cluster 1 MAbs. The thyroid gland was not blocked in order to facilitate the orientation of the scan and was clearly visible on all scintigraphic images.
On day 7 the mice were dissected and the radioactivity in each tissue was measured. The total radioactive counts varied greatly with tumour size, but all calculations for tumour tissue ratios and fraction of injected dose were done on the counts per g of tissue, which showed less variation. The mean tumour to tissue ratios 7 days after administration of the radiolabelled MAbs are shown in Figure 2 . The highest tumour to tissue ratios were observed with MAb 123C3. The tumour to blood ratio achieved with this MAb was the highest (3.97, P=0.05, Kruskal-Wallis test), twice the ratio for MAbs MOC191 and 123A8 (respectively 1.99 and 2.00). The control MAb, M6/1, showed very low ratios for all tissues tested (tumour to blood ratio 0.29). The mean fractions of the injected dose retained in the tissues on day 7 after administration of the MAbs are shown in Figure 3 . MAb 123C3 revealed the highest uptake in the tumour tissue (13.9%, P=0.04, Kruskal-Wallis test), whereas the values for MAbs MOC191 and 123A8 were significantly lower (9.2% and 6.7%). The fraction of the injected dose in the non-tumour tissues was very similar for all three tested ,ter 1 MAbs, suggesting similar pharmacokinetic behaother MAbs did not increase with time at both incubation ir. The (Figure 5a ). In Figure Sb the results of the sequently, the cells were incubated at 37°C or at 0°C. experiment with FITC-labelled MAb 123A8, without the ce internalisation is an energy-dependent process, it will treatment with the acidic buffer, are shown. The H69 cells take place at 0°C. Figure 4 shows that the fraction of showed only fluorescence at the cell surface and failed to Lb 123C3 that remained associated with the cells after show intracellular fluorescence in any of the planes, .tment with a low pH buffer increased with longer indicating that this MAb does not induce internalisation of ibation periods at 37°C, whereas most MAb could be the NCAM-MAb complex. toved from the cell surface when the cells were incubated
Active internalisation of an antigen-MAb complex )'C. In contrast, the acid-resistant fractions of both the requires adenosine triphosphate (ATP internalisation of antigens through coated pits has been described previously (Matzku et al., 1986; Press et al., 1989 . Internalisation of the NCAM-MAb complex, which was briefly reported previously by our group (Michalides et al., 1994) , may lead to a long-lasting association of the radiolabelled MAb with the cell in contrast to noninternalising MAbs that might easily dissociate from the cell surface after binding to the antigen. However, it is necessary for the retention of radioactivity that the 1251_ labelled MAb is not degraded and dehalogenated immediately after internalisation. Our results show that internalised radiolabelled MAb 123C3 is only slowly catabolised. Although the internalisation rate of NCAM-MAb 123C3 complex is relatively slow compared with the fast internalisation rate of MAbs binding to receptor molecules at the cell surface (Matzku et al., 1986; Press et al., 1989) , the degradation of 1251-MAb 123C3 is still slower than the internalisation process resulting in accumulation of radioactivity in the cell. These results are in agreement with the finding reported by Press et al. (1989) , who showed that slow internalisation of MAbs is associated with slow degradation. The fast internalising MAbs followed a pathway through the tubular endocytic compartment and the lysosomes, leading to a fast degradation. In contrast, the slow internalising MAbs showed only limited presence in these cell compartments. Apparently, antibody molecules may follow several pathways following internalisation. (Gerardy-Shahn and Eckhardt, 1994) . The internalisation of NCAM-MAb 123C3 complex does not induce internalisation of a non-internalising MAb, which binds to another epitope (unpublished data). The absence of co-internalisation of MAbs is in analogy to the findings of other investigators Casalini et al., 1991) .
In conclusion, this study suggests that the relatively high uptake of MAb 123C3 in the tumour can be attributed to internalisation. Closer attention should be paid to this property when screening antibodies for immunoscintigraphy. Our results with radiolabelled MAb 123C3 justify the use of this MAb in human studies. However, the binding to normal human tissues, such as neural tissue and natural killer cells, may cause unwanted side-effects (Moolenaar et al., 1990; Schol et al., 1988; Goldman et al., 1984) , although earlier studies with these MAbs did not report neurotoxicity or leucopenia as side-effects (Goldman et al., 1984; Lashford et al., 1987) . 
